Letter to Editor
BibTex RIS Cite

Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”

Year 2019, Volume: 3 Issue: 8, 629 - 630, 01.08.2019
https://doi.org/10.28982/josam.602855

Abstract

NA

References

  • 1. Kavak RP, Özdemir M. Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent. J Surg Med. 2019;3(7):507-11.
  • 2. Quattrocchi CC, Ramalho J, van der Molen AJ, Rovira À, Radbruch A et al. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement. Eur Radiol. 2019;29(8): 3959-67.
  • 3. Berger F, Kubik-Huch RA, Niemann T, Schmid HR, Poetzsch M, Froehlich JM et al. Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans. Radiology. 2018;288(2):703-9.
  • 4. Nehra AK, McDonald RJ, Bluhm AM, Gunderson TM, Murray DL, Jannetto PJ et al. Accumulation of gadolinium in human cerebrospinal fluid after gadobutrol-enhanced MR imaging: a prospective observational cohort study. Radiology. 2018;288(3):416-23.
  • 5. Ohashi T, Naganawa S, Ogawa E, Katagiri T, Kuno K. Signal intensity of the cerebrospinal fluid after intravenous administration of gadolinium-based contrast agents: strong contrast enhancement around the vein of Labbe. Magn Reson Med Sci. 2019;18(3):194-9.
  • 6. Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol. 2016;26(3):807-15.
  • 7. Rossi Espagnet MC, Bernardi B, Pasquini L, Figà-Talamanca L, Tomà P, Napolitano A. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children. Pediatr Radiol. 2017;47(10):1345-52.
  • 8. Agris J, Pietsch H, Balzer T. What evidence is there that gadobutrol causes increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1w MRI in patients with RRMS? Eur Radiol. 2016;26(3):816-7.
  • 9. Lancelot E, Raynaud J-S, Desché P. Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children. Pediatri Radiol. 2017;47(12):1692-3.

Re: “Makrosiklik-iyonik gadolinyum-bazlı kontrast ajan ile tekrarlanan uygulamalar ile T1 ağırlıklı kontrastsız manyetik rezonans görüntülemedeki sinyal intensite artışı”

Year 2019, Volume: 3 Issue: 8, 629 - 630, 01.08.2019
https://doi.org/10.28982/josam.602855

Abstract

References

  • 1. Kavak RP, Özdemir M. Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent. J Surg Med. 2019;3(7):507-11.
  • 2. Quattrocchi CC, Ramalho J, van der Molen AJ, Rovira À, Radbruch A et al. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement. Eur Radiol. 2019;29(8): 3959-67.
  • 3. Berger F, Kubik-Huch RA, Niemann T, Schmid HR, Poetzsch M, Froehlich JM et al. Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans. Radiology. 2018;288(2):703-9.
  • 4. Nehra AK, McDonald RJ, Bluhm AM, Gunderson TM, Murray DL, Jannetto PJ et al. Accumulation of gadolinium in human cerebrospinal fluid after gadobutrol-enhanced MR imaging: a prospective observational cohort study. Radiology. 2018;288(3):416-23.
  • 5. Ohashi T, Naganawa S, Ogawa E, Katagiri T, Kuno K. Signal intensity of the cerebrospinal fluid after intravenous administration of gadolinium-based contrast agents: strong contrast enhancement around the vein of Labbe. Magn Reson Med Sci. 2019;18(3):194-9.
  • 6. Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol. 2016;26(3):807-15.
  • 7. Rossi Espagnet MC, Bernardi B, Pasquini L, Figà-Talamanca L, Tomà P, Napolitano A. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children. Pediatr Radiol. 2017;47(10):1345-52.
  • 8. Agris J, Pietsch H, Balzer T. What evidence is there that gadobutrol causes increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1w MRI in patients with RRMS? Eur Radiol. 2016;26(3):816-7.
  • 9. Lancelot E, Raynaud J-S, Desché P. Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children. Pediatri Radiol. 2017;47(12):1692-3.
There are 9 citations in total.

Details

Primary Language English
Subjects Radiology and Organ Imaging
Journal Section Letter to editor
Authors

Sébastien Ballet 0000-0002-5184-4946

Pierre Desché This is me 0000-0002-2389-0697

Publication Date August 1, 2019
Published in Issue Year 2019 Volume: 3 Issue: 8

Cite

APA Ballet, S., & Desché, P. (2019). Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”. Journal of Surgery and Medicine, 3(8), 629-630. https://doi.org/10.28982/josam.602855
AMA Ballet S, Desché P.Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent.” J Surg Med. August 2019;3(8):629-630. doi:10.28982/josam.602855
Chicago Ballet, Sébastien, and Pierre Desché. “Re: ‘Increased Signal Intensity in the Unenhanced T1-Weighted Magnetic Resonance in the Brain After Repeated Administrations of a Macrocyclic-Ionic Gadolinium-Based Contrast agent’”. Journal of Surgery and Medicine 3, no. 8 (August 2019): 629-30. https://doi.org/10.28982/josam.602855.
EndNote Ballet S, Desché P (August 1, 2019) Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”. Journal of Surgery and Medicine 3 8 629–630.
IEEE S. Ballet and P. Desché, “Re: ‘Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent’”, J Surg Med, vol. 3, no. 8, pp. 629–630, 2019, doi: 10.28982/josam.602855.
ISNAD Ballet, Sébastien - Desché, Pierre. “Re: ‘Increased Signal Intensity in the Unenhanced T1-Weighted Magnetic Resonance in the Brain After Repeated Administrations of a Macrocyclic-Ionic Gadolinium-Based Contrast agent’”. Journal of Surgery and Medicine 3/8 (August 2019), 629-630. https://doi.org/10.28982/josam.602855.
JAMA Ballet S, Desché P. Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”. J Surg Med. 2019;3:629–630.
MLA Ballet, Sébastien and Pierre Desché. “Re: ‘Increased Signal Intensity in the Unenhanced T1-Weighted Magnetic Resonance in the Brain After Repeated Administrations of a Macrocyclic-Ionic Gadolinium-Based Contrast agent’”. Journal of Surgery and Medicine, vol. 3, no. 8, 2019, pp. 629-30, doi:10.28982/josam.602855.
Vancouver Ballet S, Desché P. Re: “Increased signal intensity in the unenhanced T1-weighted magnetic resonance in the brain after repeated administrations of a macrocyclic-ionic gadolinium-based contrast agent”. J Surg Med. 2019;3(8):629-30.